Research Catalog

  • Drug shortage crisis : lives are in the balance : hearing before the Subcommittee on Health Care, District of Columbia, Census, and the National Archives of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Twelfth Congress, first session, November 30, 2011.

    • Text
    • Washington : U.S. G.P.O., 2012.
    • 2012
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo21319
  • Drug shortage crisis [microform] : lives are in the balance : hearing before the Subcommittee on Health Care, District of Columbia, Census, and the National Archives of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Twelfth Congress, first session, November 30, 2011.

    • Text
    • Washington : U.S. G.P.O., 2012.
    • 2012
  • Drug shortages : why they happen and what they mean : hearing before the Committee on Finance, United States Senate, One Hundred Twelfth Congress, first session, December 7, 2011.

    • Text
    • Washington : U.S. Government Printing Office, 2011.
    • 2011
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo34024
  • Drug shortages : why they happen and what they mean : hearing before the Committee on Finance, United States Senate, One Hundred Twelfth Congress, first session, December 7, 2011.

    • Text
    • [Washington, D.C.] : U.S. Government Printing Office, [2013]
    • 2013
  • Short-supply prescription drugs : shining a light on the gray market : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Twelfth Congress, second session, July 25, 2012.

    • Text
    • [Washington, D.C.] : U.S. Government Printing Office, [2013]
    • 2013
  • Examining the increase in drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, September 23, 2011.

    • Text
    • [Washington, D.C.] : U.S. Government Printing Office, [2013]
    • 2013
  • Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.

    • Text
    • [Washington, D.C.] : U.S. Government Printing Office, [2013]
    • 2013
  • Prescription drug shortages : examining a public health concern and potential solutions : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, first session ... December 15, 2011.

    • Text
    • Washington : U.S. Government Printing Office, 2014.
    • 2014
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo50659
  • Ensuring Patient Access and Effective Drug Enforcement Act of 2014 : report (to accompany H.R. 4709) (including cost estimate of the Congressional Budget Office).

    • Text
    • [Washington, D.C.] : [U.S. Government Printing Office], [2014]-
    • 2014-present
    • 2 Resources

    Available Online

    See All Available Online Resources

  • Drug shortages, threat to public health persists, despite actions to help maintain product availability : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives / statement of Marcia Crosse.

    • Text
    • [Washington, D.C.] : United States Government Accountability Office, 2014.
    • 2014
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo52066
  • Drug shortages, public health threat continues, despite efforts to help ensure product availability : report to congressional addressees.

    • Text
    • [Washington, D.C.] : United States Government Accountability Office, 2014.
    • 2014
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo52065
  • Examining drug shortages and recent efforts to address them : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, February 10, 2014.

    • Text
    • Washington : U.S. Government Printing Office, 2014.
    • 2014
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo53017
  • Prescription drug shortages : examining a public health concern and potential solutions : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, first session ... December 15, 2011.

    • Text
    • [Washington, District of Columbia] : U.S. Government Printing Office, [2014]
    • 2014
  • Ensuring Patient Access and Effective Drug Enforcement Act of 2014 : report (to accompany H.R. 4709) (including cost estimate of the Congressional Budget Office).

    • Text
    • [Washington, D.C.] : U.S. Government Printing Office, [2014]-
    • 2014-present
  • Examining drug shortages and recent efforts to address them : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, February 10, 2014.

    • Text
    • [Washington, D.C.] : U.S. Government Printing Office, [2014]
    • 2014
  • Ensuring Patient Access and Effective Drug Enforcement Act of 2015 : report (to accompany H.R. 471) (including cost estimate of the Congressional Budget Office).

    • Text
    • [Washington, D.C.] : [U.S. Government Publishing Office], [2015]-
    • 2015-present
    • 2 Resources

    Available Online

    See All Available Online Resources

  • Acesso a medicamentos : direito ou utopia? / Jorge Bermudez.

    • Text
    • Rio de Janeiro : E-papers, 2014.
    • 2014-2014
    • 1 Item
    FormatCall NumberItem Location
    Text ReCAP 15-33617Offsite
  • Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014.

    • Text
    • Washington : U.S. Government Publishing Office, 2015.
    • 2015
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo59306
  • Ensuring Patient Access and Effective Drug Enforcement Act of 2015 : report (to accompany H.R. 471) (including cost estimate of the Congressional Budget Office).

    • Text
    • [Washington, D.C.] : [U.S. Government Publishing Office], [2015]-
    • 2015-present
  • Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014.

    • Text
    • Washington : U.S. Government Publishing Office, 2015.
    • 2015
  • Ensuring Patient Access and Effective Drug Enforcement Act of 2016.

    • Text
    • [Washington, D.C.] : [U.S. Government Publishing Office], [2016]
    • 2016
    • 2 Resources

    Available Online

    See All Available Online Resources

  • Drug shortages, certain factors are strongly associated with this persistent public health challenge : report to congressional committee.

    • Text
    • [Washington, D.C.] : United States Government Accountability Office, 2016.
    • 2016
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo69777
  • Of medicines and markets : intellectual property and human rights in the free trade era / Angelina Snodgrass Godoy.

    • Text
    • Stanford, California : Stanford University Press, 2013.
    • 2013
    • 1 Item
    FormatCall NumberItem Location
    Text JBD 16-292Schwarzman Building - General Research Room 315

    Available - Can be used on site. Please visit New York Public Library - Schwarzman Building to submit a request in person.

  • NGO perspectives on access to HIV-related drugs in 13 Latin American and Caribbean countries.

    • Text
    • [Geneva, Switzerland] : UNAIDS, [1998]
    • 1998-1998
    • 1 Resource

    Available Online

    http://find.galegroup.com/openurl/openurl?url_ver=Z39.88-2004&url_ctx_fmt=info:ofi/fmt:kev:mtx:ctx&res_id=info:sid/gale:AHSI&ctx_enc=info:ofi:enc:UTF-8&rft_val_fmt=info:ofi/fmt:kev:mtx:unknown&rft.artnum=AGEQRK758266201&req_dat=info:sid/gale:ugnid:nypl
  • Economic analysis of the causes of drug shortages.

    • Text
    • Washington, DC : Office of the Assistant Secretary for Planning and Evaluation, Office of Science and Data Policy, U.S. Department of Health and Human Services, 2011.
    • 2011
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo78101
  • Patentes e o acesso a antirretrovirais no Brasil : o desafio do licenciamento compulsório / João Nunes, Rosana Curzel (organizadores).

    • Text
    • Curitiba, PR : Appris Editora, 2017.
    • 2017-2017
    • 1 Item
    FormatCall NumberItem Location
    Text ReCAP 18-5111Offsite
  • Examining FDA's Prescription Drug User Fee program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.

    • Text
    • Washington : U.S. Government Publishing Office, 2018.
    • 2018
  • Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining generic drug user fee amendments, focusing on accelerating patient access to generic drugs, January 28, 2016.

    • Text
    • Washington : U.S. Government Publishing Office, 2018.
    • 2018
  • Examining oversight reports on the 340B Drug Pricing Program : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining oversight reports on the 340B Drug Pricing Program, May 15, 2018.

    • Text
    • Washington : U.S. Government Publishing Office, 2020.
    • 2020
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo139085
  • Desenvolvimento econômico do Brasil e o Programa Aqui tem Farmácia Popular : limitantes e potencialidades / Wendy Beatriz Witt Haddad Carraro.

    • Text
    • Curitiba, PR : Brazil Publishing, 2020.
    • 2020
    • 1 Item
    FormatCall NumberItem Location
    Text JX 21-9643Schwarzman Building - General Research Room 315

    Available - Can be used on site. Please visit New York Public Library - Schwarzman Building to submit a request in person.

  • La santé hors de prix : l'affaire Sovaldi / Olivier Maguet.

    • Text
    • Paris : Raisons d'agir éditions, [2020]
    • 2020-2020
    • 1 Item
    FormatCall NumberItem Location
    Text ReCAP 21-108321Offsite
  • Easy Medication Access and Treatment for Opioid Addiction Act : report (to accompany H.R. 2281).

    • Text
    • [Washington, D.C.] : [U.S. Government Publishing Office], [2020]-
    • 2020-present
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo148390
  • Short-supply prescription drugs : shining a light on the gray market : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Twelfth Congress, second session, July 25, 2012.

    • Text
    • Washington : U.S. Government Printing Office, 2013.
    • 2013
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo35313
  • Examining the increase in drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, September 23, 2011.

    • Text
    • Washington : U.S. Government Printing Office, 2013.
    • 2013
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo35983
  • Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012.

    • Text
    • Washington : U.S. Government Printing Office, 2013.
    • 2013
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo39088
  • Opportunities to improve the 340B drug pricing program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, July 11, 2018.

    • Text
    • Washington : U.S. Government Publishing Office, 2019.
    • 2019
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo157380
  • Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017.

    • Text
    • Washington : U.S. Government Publishing Office, 2018.
    • 2018
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo157392
  • Accelerating Access to Critical Therapies for ALS Act : report (to accompany H.R. 3537).

    • Text
    • [Washington, D.C.] : [U.S. Government Publishing Office], [2021]
    • 2021
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo172859
  • América Latina : audiencia sobre acceso a medicamentos celebrada por la Comisión Interamericana de Derechos Humanos (CIDH) / organizadores: Felipe Fonseca, Pedro Villardi, Yusseff Abrahim.

    • Text
    • [Rio de Janeiro] : [ABIA - Associação Brasileira Interdisciplinar de AIDS], [2019]
    • 2019
    • 1 Item
    FormatCall NumberItem Location
    Text JX 22-27550Schwarzman Building - General Research Room 315

    Available - Can be used on site. Please visit New York Public Library - Schwarzman Building to submit a request in person.

  • Drug discount program: federal oversight of compliance at 340B contract pharmacies needs improvement : report to congressional requesters.

    • Text
    • [Washington, D.C.] : United States. Government Accountability Office, 2018.
    • 2018
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo175592
  • Drug Discount Program : characteristics of hospitals participating and not participating In the 340B program.

    • Text
    • Washington, DC : U.S. Government Accountability Office, 2018.
    • 2018
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo175595
  • Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017.

    • Text
    • Washington : U.S. Government Publishing Office, 2018.
    • 2018
  • Opportunities to improve the 340B drug pricing program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, July 11, 2018.

    • Text
    • Washington : U.S. Government Publishing Office, 2019.
    • 2019
  • Examining oversight reports on the 340B Drug Pricing Program : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining oversight reports on the 340B Drug Pricing Program, May 15, 2018.

    • Text
    • Washington : U.S. Government Publishing Office, 2020.
    • 2020
  • The complex web of prescription drug prices : examining agency efforts to further competition and increase affordability : hearing before the Special Committee on Aging, United States Senate, One Hundred Sixteenth Congress, first session, Washington, DC, June 19, 2019.

    • Text
    • Washington : U.S. Government Publishing Office, 2022.
    • 2022
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo183063
  • Lowering prescription drug prices : deconstructing the drug supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 9, 2019.

    • Text
    • Washington, DC : United States Government Publishing Office, 2021.
    • 2021
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo187077
  • La santé en bande organisée : enquête / Anne Jouan, professeur Christian Riché.

    • Text
    • Paris : Robert Laffont, [2022]
    • 2022-2022
    • 1 Item
    FormatCall NumberItem Location
    Text ReCAP 22-113345Offsite
  • Prescription for the people [electronic resource] : an activist's guide to making medicine affordable for all / Fran Quigley.

    • Text
    • Ithaca : ILR Press, an imprint of Cornell University Press, 2017.
    • 2017
    • 2 Resources

    Available Online

    See All Available Online Resources

  • Short supply : the health and national security risks of drug shortages : HSGAC majority staff report.

    • Text
    • [Washington, DC] : United States Senate Committee on Homeland Security & Governmental Affairs, 2023.
    • 2023
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo194920
  • Drug shortage health and national security risks : underlying causes and needed reforms : hearing before the Committee on Homeland Security and Governmental Affairs, United States Senate, One Hundred Eighteenth Congress, first session, March 22, 2023.

    • Text
    • Washington : U.S. Government Publishing Office, 2023.
    • 2023
    • 1 Resource

    Available Online

    https://purl.fdlp.gov/GPO/gpo215511

No results found from Digital Research Books Beta

Digital books for research from multiple sources world wide- all free to read, download, and keep. No Library Card is Required. Read more about the project.

digital-research-book
Explore Digital Research Books Beta